Wave Life Sciences, Inc. (WVE)
NASDAQ: WVE · Real-Time Price · USD
2.560
-0.160 (-5.88%)
At close: Nov 20, 2026, 4:00 PM EST
2.600
+0.040 (1.56%)
After-hours: Nov 20, 2026, 7:33 PM EST
Wave Life Sciences Revenue
Wave Life Sciences had revenue of $13.16M in the quarter ending September 30, 2026, with 72.95% growth. This brings the company's total for the last twelve months to $70.92M, down -35.07% year-over-year. In the year 2025, Wave Life Sciences had annual revenue of $42.73M, down -60.55%. That makes Wave Life Sciences the 25,390th largest company in the world by revenue and 3,525th in the United States.
Revenue (ttm)
$70.92M
Revenue Growth
-35.07%
P/S Ratio
7.12
Revenue / Employee
$223,726
Employees
317
Market Cap
504.91M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.73M | -65.58M | -60.55% |
| Dec 31, 2024 | 108.30M | -5.00M | -4.42% |
| Dec 31, 2023 | 113.31M | 109.66M | 3,005.10% |
| Dec 31, 2022 | 3.65M | -37.32M | -91.09% |
| Dec 31, 2021 | 40.96M | 20.89M | 104.03% |
| Dec 31, 2020 | 20.08M | 4.09M | 25.61% |
| Dec 31, 2019 | 15.98M | 1.57M | 10.89% |
| Dec 31, 2018 | 14.41M | 10.52M | 270.25% |
| Dec 31, 2017 | 3.89M | 2.80M | 256.50% |
| Dec 31, 2016 | 1.09M | 940.00K | 618.42% |
| Dec 31, 2015 | 152.00K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zevra Therapeutics | 147.76M |
| Ginkgo Bioworks Holdings | 130.75M |
| Adlai Nortye Group | 18.06M |
| Crescent Biopharma | 15.00M |
| Alumis | 7.24M |
| Aclaris Therapeutics | 6.40M |
| Entera Bio | 42.00K |
WVE News
- 3 days ago - Wave Life Sciences Transcript: Jefferies Global Healthcare Conference - Transcripts
- 8 days ago - Wave Life Sciences Highlights WVE-007 (INHBE siRNA) Progress at ObesityWeek® 2026 - GlobeNewsWire
- 9 days ago - Wave Life Sciences price target lowered to $15 from $19 at Citi - TheFly
- 10 days ago - Wave Life Sciences to Present at Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 12 days ago - Wave Life Sciences price target lowered to $18 from $22 at B. Riley - TheFly
- 17 days ago - Wave Life Sciences Transcript: R&D Day 2026 - Transcripts
- 17 days ago - Wave Life Sciences Slides: FY 2026 - Filings
- 17 days ago - Wave Life Sciences price target lowered to $16 from $17 at BofA - TheFly